Concepedia

Jinshan Shen

JS

8

Publications

321

Citations

8

H-Index

1998

Active since

Affiliations

Massachusetts General Hospital(Current)

The University of Texas MD Anderson Cancer Center

Mayo Clinic in Arizona

Cleveland Clinic

Memorial Sloan Kettering Cancer Center

Jinshan Shen is an author at Massachusetts General Hospital specializing in medicine, cancer therapeutics, and tumor biology.

ORCID

Top concepts

Publications per year

1998–2021

8

Publications

8

Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

Flavio Vincenti, Gilles Blancho, Antoine Dürrbach et al. · Journal of the American Society of Nephrology · 2010 · 184 citations · Full text

, , +14

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients

Jinshan Shen, Robert Townsend, Xiaoli X. You et al. · Clinical Drug Investigation · 2013 · 39 citations · Full text

Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor

Varun Garg, Jinshan Shen, Chonghua Li et al. · Clinical and Translational Science · 2019 · 35 citations · Full text

A phase 2 study to evaluate the safety, efficacy and pharmacokinetics of DP2 antagonist GB001 and to explore biomarkers of airway inflammation in mild‐to‐moderate asthma

Héctor Ortega, Mary Fitzgerald, Kartik Raghupathi et al. · Clinical & Experimental Allergy · 2019 · 16 citations · Full text

First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors.

Alison M. Schram, Suneel D. Kamath, Anthony B. El-Khoueiry et al. · Journal of Clinical Oncology · 2021 · 14 citations

, , +16

Rows per page

1–5 of 8